September 24, 2014
Vertex Pharmaceuticals Inc. and Gilead Sciences Inc. asked a Massachusetts federal judge on Wednesday to dismiss a trade-secrets suit accusing Gilead of poaching a high-level Vertex employee with access to confidential data on its soon-to-be-discontinued Incivek hepatitis C drug, after they reached a settlement.
March 28, 2013
Vertex Pharmaceuticals Inc. slapped rival Gilead Sciences Inc. with a trade secrets lawsuit Wednesday for allegedly poaching a high-level Vertex physician liaison with access to troves of confidential data on its Incivek hepatitis C drug, saying it gives Gilead an unfair advantage as it plans to launch a competing treatment.